Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,909 | 63,745 | 73,296 | 82,421 | 42,790 |
| Marketable Securities | 8,045 | 10,695 | 9,715 | 8,535 | 6,575 |
| Receivables | 925 | 981 | 830 | 904 | 680 |
| Inventories | 146 | 161 | 150 | 143 | 164 |
| TOTAL | $66,523 | $76,848 | $85,342 | $93,080 | $51,875 |
| Non-Current Assets | |||||
| PPE Net | 890 | 1,096 | 1,302 | 1,526 | 1,764 |
| Intangibles | 198 | 712 | 264 | 221 | 223 |
| TOTAL | $1,088 | $1,808 | $1,566 | $1,747 | $1,987 |
| Total Assets | $67,611 | $78,656 | $86,908 | $94,827 | $53,862 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 937 | 1,219 | 829 | 1,139 | 658 |
| Accrued Expenses | 4,671 | 4,614 | 4,367 | 3,765 | 2,576 |
| TOTAL | $5,608 | $5,833 | $5,196 | $4,904 | $3,234 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 235 | 949 | 240 | 217 | 246 |
| TOTAL | $235 | $949 | $240 | $217 | $246 |
| Total Liabilities | $5,843 | $6,782 | $5,436 | $5,121 | $3,480 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45 | 45 | 45 | 45 | 37 |
| Common Shares | 63 | 63 | 63 | 63 | 52 |
| Retained earnings | -397,254 | -386,174 | -375,492 | -366,148 | -355,475 |
| TOTAL | $61,768 | $71,874 | $81,472 | $89,706 | $50,382 |
| Total Liabilities And Equity | $67,611 | $78,656 | $86,908 | $94,827 | $53,862 |